TY - JOUR
T1 - The aftercare of the patient with the neuroleptic malignant syndrome
AU - Aizenberg, D.
AU - Shalev, A.
AU - Munitz, H.
PY - 1985
Y1 - 1985
N2 - The neuroleptic malignant syndrome (NMS) is an idiosyncratic reaction to neuroleptic drugs, made up of hyperthermia, muscular rigidity, disturbance of level of consciousness and autonomic dysfunction. It is potentially lethal and should be kept in mind whilst using anti-psychotic drugs; as most patients treated by them require further anti-psychotic treatment, the clinician faces the problem of treating those patients after a NMS episode, yet reports in the literature have generally neglected the problem of late management. A patient suffering from a psychosis and NMS is presented, and a rationale for management offered.
AB - The neuroleptic malignant syndrome (NMS) is an idiosyncratic reaction to neuroleptic drugs, made up of hyperthermia, muscular rigidity, disturbance of level of consciousness and autonomic dysfunction. It is potentially lethal and should be kept in mind whilst using anti-psychotic drugs; as most patients treated by them require further anti-psychotic treatment, the clinician faces the problem of treating those patients after a NMS episode, yet reports in the literature have generally neglected the problem of late management. A patient suffering from a psychosis and NMS is presented, and a rationale for management offered.
UR - http://www.scopus.com/inward/record.url?scp=0021957240&partnerID=8YFLogxK
U2 - 10.1192/bjp.146.3.317
DO - 10.1192/bjp.146.3.317
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0021957240
SN - 0007-1250
VL - 146
SP - 317
EP - 318
JO - British Journal of Psychiatry
JF - British Journal of Psychiatry
IS - MAR.
ER -